drugset

drugset / Trial / NCT02815774

SP2086 Pharmacokinetic Study in Renal Insufficiency Patients

NCT02815774 ↗

Phase 1 Completed 30 enrolled Jiangsu HengRui Medicine Co., Ltd.

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to investigate the SP2086 pharmacokinetic in Renal Insufficiency Patients.

Timeline

Start: 2014-06
Primary completion: 2015-01
Completion: 2015-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Retagliptin	Small molecule	50 mg	—

Indications